Keimyung University
Also known as: 82532584892 | Department of Internal Medicine, Keimyung University Dongsan Medical Center | Department of Oncology/Keimyung University Dongsan Medical Center | Dongsan Hospital | Dongsan Medical Center | Keimyug University Dongsan Medical Center | Keimyung Univ. Dongsan Medical Center | Keimyung University | Keimyung University Dongsan Medical Center | Keimyung University, Donsan Hospital | Keimyung University School of Medicine | Keimyung Universtiy Dongsan Medical Center | The Dongsan Medical Center of Keimyung University
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Oct 15, 2024
Timeline
1950s
- Jan 1, 1954
Keimyung University— Founded
Drugs by trial phase (66 distinct, 52 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Atrial Fibrillation
- Cancer Pain
- Carcinoma in Situ
- Cervical Intraepithelial Neoplasia
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Crohn Disease
- Diabetic Foot
- Dyspepsia
- Epilepsies, Partial
- Epilepsy
- Essential Hypertension
- Foot Ulcer
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypertension
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Chronic-Phase
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lymphoma
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Musculoskeletal Pain
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Osteoarthritis
- Osteoarthritis, Knee
- Pharyngitis
- Premature Birth
- Pulmonary Disease, Chronic Obstructive
- Sleep Initiation and Maintenance Disorders
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stomach Ulcer
- Stroke
- Tachycardia
- Tachycardia, Ventricular
- Thrombosis
- Ulcer
- Urinary Bladder, Neurogenic
- Ventricular Premature Complexes
Recent trials (50)
- NCT06580717OfficialPhase 4Oct 15, 2024
- NCT05845489CollaboratorPhase 4Mar 9, 2023
- NCT05257824CollaboratorPhase 4Jun 23, 2022
- NCT04427930Overall official - principal investigatorPhase 3Apr 13, 2020
- NCT04247373Reponsible party - principal investigatorN/AJan 31, 2020
- NCT04247373Lead sponsorN/AJan 31, 2020
- NCT04247373Overall official - principal investigatorN/AJan 31, 2020
- NCT03840291Lead sponsorPhase 4Aug 31, 2019
- NCT03840291Study chairPhase 4Aug 31, 2019
- NCT03840291Reponsible party - principal investigatorPhase 4Aug 31, 2019
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03990805Overall official - principal investigatorPhase 3Jun 11, 2019
- NCT03950843Overall official - principal investigatorPhase 3Apr 23, 2019
- NCT03607851CollaboratorPhase 4Jul 31, 2018
- NCT03370874Overall official - principal investigatorPhase 3Jul 4, 2018
Details
- Founded
- Daegu, KR Jan 1, 1954
- Last known activity
- Oct 15, 2024